Amedeo Smart

Free Medical Literature Service

 

Amedeo

Prostate Cancer
  Free Subscription

Articles published in
Proc Natl Acad Sci U S A
    September 2025
  1. CHOWDHURY SR, Parikh CN, Kaur AN, DeMarco KD, et al
    PPT1 is a negative regulator of STING signaling in cancer cells and its inhibition reactivates immune surveillance in cold tumors.
    Proc Natl Acad Sci U S A. 2025;122:e2514948122.
    >> Share

  2. CHO H, Zhang Y, Tien JC, Mannan R, et al
    Cellular cartography reveals mouse prostate organization and determinants of castration resistance.
    Proc Natl Acad Sci U S A. 2025;122:e2427116122.
    >> Share

    July 2025

  3. Retraction for Kundu et al., Selective neutralization of IL-12 p40 monomer induces death in prostate cancer cells via IL-12-IFN-gamma.
    Proc Natl Acad Sci U S A. 2025;122:e2516531122.
    >> Share

  4. HE D, Zhang L, Yu L, Zhang Y, et al
    Fine structural design of 3betaHSD1 inhibitors for prostate cancer therapy.
    Proc Natl Acad Sci U S A. 2025;122:e2422267122.
    >> Share

  5. SUSHENTSEV N, Hamm G, Manavaki R, McLean MA, et al
    Spatial metabolomics informs the use of clinical imaging for improved detection of cribriform prostate cancer.
    Proc Natl Acad Sci U S A. 2025;122:e2502423122.
    >> Share

    June 2025
  6. PAPPAS K, Ferrari M, Smith P, Nandakumar S, et al
    BRCA2 reversion mutation-independent resistance to PARP inhibition through impaired DNA prereplication complex function.
    Proc Natl Acad Sci U S A. 2025;122:e2426743122.
    >> Share

    April 2025

  7. Correction for Pitzen et al., Comparative transcriptomics reveals a mixed basal, club, and hillock epithelial cell identity in castration-resistant prostate cancer.
    Proc Natl Acad Sci U S A. 2025;122:e2504762122.
    >> Share

    March 2025
  8. LEE J, Park J, Hur Y, Um D, et al
    ETV5 reduces androgen receptor expression and induces neural stem-like properties during neuroendocrine prostate cancer development.
    Proc Natl Acad Sci U S A. 2025;122:e2420313122.
    >> Share

    February 2025
  9. PITZEN SP, Rudenick AN, Qiu Y, Zhang W, et al
    Comparative transcriptomics reveals a mixed basal, club, and hillock epithelial cell identity in castration-resistant prostate cancer.
    Proc Natl Acad Sci U S A. 2025;122:e2415308122.
    >> Share

    December 2024
  10. VARUZHANYAN G, Chen CC, Freeland J, He T, et al
    PGC-1alpha drives small cell neuroendocrine cancer progression toward an ASCL1-expressing subtype with increased mitochondrial capacity.
    Proc Natl Acad Sci U S A. 2024;121:e2416882121.
    >> Share

    November 2024
  11. KOHRT SE, Novak EJ, Tapadar S, Wu B, et al
    Small-molecule disruption of androgen receptor-dependent chromatin clusters.
    Proc Natl Acad Sci U S A. 2024;121:e2406239121.
    >> Share

    October 2024
  12. WANG Z, Yu H, Bao W, Qu M, et al
    Proteomic and phosphoproteomic landscape of localized prostate cancer unveils distinct molecular subtypes and insights into precision therapeutics.
    Proc Natl Acad Sci U S A. 2024;121:e2402741121.
    >> Share

    September 2024
  13. SU XA, Stopsack KH, Schmidt DR, Ma D, et al
    RAD21 promotes oncogenesis and lethal progression of prostate cancer.
    Proc Natl Acad Sci U S A. 2024;121:e2405543121.
    >> Share

    August 2024
  14. YU G, Corn PG, Mak CSL, Liang X, et al
    Prostate cancer-induced endothelial-cell-to-osteoblast transition drives immunosuppression in the bone-tumor microenvironment through Wnt pathway-induced M2 macrophage polarization.
    Proc Natl Acad Sci U S A. 2024;121:e2402903121.
    >> Share

    July 2024
  15. PORNOUR M, Jeon HY, Ryu H, Khadka S, et al
    USP11 promotes prostate cancer progression by up-regulating AR and c-Myc activity.
    Proc Natl Acad Sci U S A. 2024;121:e2403331121.
    >> Share

  16. ZAIDI S, Park J, Chan JM, Roudier MP, et al
    Single-cell analysis of treatment-resistant prostate cancer: Implications of cell state changes for cell surface antigen-targeted therapies.
    Proc Natl Acad Sci U S A. 2024;121:e2322203121.
    >> Share

    April 2024
  17. HE T, Cheng C, Qiao Y, Cho H, et al
    Development of an orally bioavailable mSWI/SNF ATPase degrader and acquired mechanisms of resistance in prostate cancer.
    Proc Natl Acad Sci U S A. 2024;121:e2322563121.
    >> Share

    December 2023
  18. SUSHENTSEV N, Hamm G, Richings J, McLean MA, et al
    Imaging tumor lactate is feasible for identifying intermediate-risk prostate cancer patients with postsurgical biochemical recurrence.
    Proc Natl Acad Sci U S A. 2023;120:e2312261120.
    >> Share

    November 2023
  19. MAJI S, Pradhan AK, Kumar A, Bhoopathi P, et al
    MDA-9/Syntenin in the tumor and microenvironment defines prostate cancer bone metastasis.
    Proc Natl Acad Sci U S A. 2023;120:e2307094120.
    >> Share


Free Medical Abstracts
Privacy Policy
Sponsors
Share

© Amedeo 1997-2016